CA2374631A1 - Derives du benzene, procede de preparation et compositions pharmaceutiques les contenant - Google Patents
Derives du benzene, procede de preparation et compositions pharmaceutiques les contenant Download PDFInfo
- Publication number
- CA2374631A1 CA2374631A1 CA002374631A CA2374631A CA2374631A1 CA 2374631 A1 CA2374631 A1 CA 2374631A1 CA 002374631 A CA002374631 A CA 002374631A CA 2374631 A CA2374631 A CA 2374631A CA 2374631 A1 CA2374631 A1 CA 2374631A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- compound
- atom
- hydrogen
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title claims 8
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- 150000001875 compounds Chemical class 0.000 claims abstract 30
- 229910052801 chlorine Inorganic materials 0.000 claims 13
- 125000001309 chloro group Chemical group Cl* 0.000 claims 9
- -1 bicyclo[3.2.1]octanyl Chemical group 0.000 claims 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 8
- 229910052731 fluorine Chemical group 0.000 claims 7
- 125000001153 fluoro group Chemical group F* 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- 239000002253 acid Substances 0.000 claims 5
- 150000007513 acids Chemical class 0.000 claims 5
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 5
- 150000004677 hydrates Chemical class 0.000 claims 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 5
- AGVKXDPPPSLISR-UHFFFAOYSA-N n-ethylcyclohexanamine Chemical compound CCNC1CCCCC1 AGVKXDPPPSLISR-UHFFFAOYSA-N 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 239000012453 solvate Substances 0.000 claims 5
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical group ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims 4
- 125000003670 adamantan-2-yl group Chemical group [H]C1([H])C(C2([H])[H])([H])C([H])([H])C3([H])C([*])([H])C1([H])C([H])([H])C2([H])C3([H])[H] 0.000 claims 4
- 150000001412 amines Chemical class 0.000 claims 4
- 239000000460 chlorine Chemical group 0.000 claims 4
- 125000004487 4-tetrahydropyranyl group Chemical group [H]C1([H])OC([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 3
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 3
- 238000005984 hydrogenation reaction Methods 0.000 claims 3
- 229910052740 iodine Inorganic materials 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 229940126601 medicinal product Drugs 0.000 claims 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 3
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 2
- 125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 claims 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 150000001638 boron Chemical class 0.000 claims 2
- 229910052794 bromium Inorganic materials 0.000 claims 2
- 239000003054 catalyst Substances 0.000 claims 2
- 238000005859 coupling reaction Methods 0.000 claims 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 claims 2
- 125000004342 dicyclopropylmethyl group Chemical group [H]C1([H])C([H])([H])C1([H])C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims 2
- 239000011737 fluorine Substances 0.000 claims 2
- 239000011630 iodine Substances 0.000 claims 2
- 150000002576 ketones Chemical class 0.000 claims 2
- 239000002184 metal Substances 0.000 claims 2
- 229910052751 metal Inorganic materials 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 claims 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 claims 1
- 241001484259 Lacuna Species 0.000 claims 1
- 238000006683 Mannich reaction Methods 0.000 claims 1
- 238000006069 Suzuki reaction reaction Methods 0.000 claims 1
- FOWDOWQYRZXQDP-UHFFFAOYSA-N adamantan-2-ol Chemical group C1C(C2)CC3CC1C(O)C2C3 FOWDOWQYRZXQDP-UHFFFAOYSA-N 0.000 claims 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 229910052987 metal hydride Inorganic materials 0.000 claims 1
- 150000004681 metal hydrides Chemical class 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 210000004881 tumor cell Anatomy 0.000 claims 1
- 210000001428 peripheral nervous system Anatomy 0.000 abstract 1
- 108010085082 sigma receptors Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/40—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing only non-condensed rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR99/07396 | 1999-06-11 | ||
| FR9907396A FR2794742B1 (fr) | 1999-06-11 | 1999-06-11 | Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant |
| PCT/FR2000/001575 WO2000076953A1 (fr) | 1999-06-11 | 2000-06-08 | Derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2374631A1 true CA2374631A1 (fr) | 2000-12-21 |
| CA2374631C CA2374631C (fr) | 2010-10-19 |
Family
ID=9546664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2374631A Expired - Fee Related CA2374631C (fr) | 1999-06-11 | 2000-06-08 | Derives du benzene, procede de preparation et compositions pharmaceutiques les contenant |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US6482986B1 (fr) |
| EP (1) | EP1192122B1 (fr) |
| JP (1) | JP4711579B2 (fr) |
| KR (1) | KR100668581B1 (fr) |
| CN (1) | CN1210250C (fr) |
| AR (1) | AR033793A1 (fr) |
| AT (1) | ATE252542T1 (fr) |
| AU (1) | AU768420B2 (fr) |
| BR (1) | BR0011738A (fr) |
| CA (1) | CA2374631C (fr) |
| CO (1) | CO5180554A1 (fr) |
| CZ (1) | CZ299659B6 (fr) |
| DE (1) | DE60006113T2 (fr) |
| DK (1) | DK1192122T3 (fr) |
| ES (1) | ES2208345T3 (fr) |
| FR (1) | FR2794742B1 (fr) |
| HK (1) | HK1042891B (fr) |
| HU (1) | HU228683B1 (fr) |
| IL (1) | IL146545A0 (fr) |
| MX (1) | MXPA01012783A (fr) |
| NO (1) | NO327778B1 (fr) |
| NZ (1) | NZ515529A (fr) |
| PL (1) | PL196491B1 (fr) |
| PT (1) | PT1192122E (fr) |
| RS (1) | RS49998B (fr) |
| RU (1) | RU2248964C2 (fr) |
| SI (1) | SI1192122T1 (fr) |
| SK (1) | SK286390B6 (fr) |
| TW (1) | TWI279398B (fr) |
| UA (1) | UA71959C2 (fr) |
| UY (1) | UY26199A1 (fr) |
| WO (1) | WO2000076953A1 (fr) |
| ZA (1) | ZA200109486B (fr) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10110750A1 (de) * | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
| GB2410947B (en) * | 2004-02-11 | 2008-09-17 | Cambridge Lab Ltd | Pharmaceutical compounds |
| US20110104186A1 (en) | 2004-06-24 | 2011-05-05 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
| EP1634598A1 (fr) * | 2004-09-07 | 2006-03-15 | Laboratorios Del Dr. Esteve, S.A. | Utilisation de dérivés de piperazine et ses analogues pour prevenir et traiter des désordres liés à l'ingestion de nourriture |
| CN101184732B (zh) * | 2005-03-28 | 2012-05-16 | 株式会社半导体能源研究所 | 蒽衍生物、发光元件用材料、发光元件、发光装置和电子器件 |
| FR2887454B1 (fr) * | 2005-06-28 | 2009-06-05 | Sanofi Aventis Sa | Combinaisons antitumorales contenant des derives du taxane et des sigma ligands |
| GB0514501D0 (en) * | 2005-07-14 | 2005-08-24 | Cambridge Lab Ireland Ltd | Pharmaceutical compounds |
| GB0516168D0 (en) * | 2005-08-05 | 2005-09-14 | Cambridge Lab Ireland Ltd | Pharmaceutical compounds |
| US7731377B2 (en) * | 2006-03-21 | 2010-06-08 | Semiconductor Energy Laboratory Co., Ltd. | Backlight device and display device |
| CN101506163B (zh) * | 2006-08-30 | 2012-05-02 | 株式会社半导体能源研究所 | 合成蒽衍生物的方法和蒽衍生物、发光元件、发光装置、电子装置 |
| GR1005865B (el) * | 2007-01-17 | 2008-04-07 | Anavex Life Sciences Corp. | Νεοι συνδετες των σιγμα υποδοχεων με αντι-αποπτωτικες και/η προ-αποπτωτικες ιδιοτητες επι των κυτταρικων βιοχημικων μηχανισμων, με νευρο-προστατευτικη, αντικαρκινικη, αντι-μεταστατικη και αντι- αντι-(χρονιο)φλεγμονικη δραση. |
| US7723722B2 (en) | 2007-03-23 | 2010-05-25 | Semiconductor Energy Laboratory Co., Ltd. | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative |
| FR2915994B1 (fr) * | 2007-05-11 | 2009-07-03 | Galderma Res & Dev | Procede de synthese de l'acide (z)-3-[2-butoxy-3'-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl] -2-methoxy-acrylique. |
| US20080286445A1 (en) * | 2007-05-17 | 2008-11-20 | Semiconductor Energy Laboratory Co., Ltd. | Composition, and method of fabricating light-emitting element |
| GB0810857D0 (en) * | 2008-06-13 | 2008-07-23 | Cambridge Lab Ireland Ltd | Pharmaceutical compounds |
| WO2010005066A1 (fr) * | 2008-07-08 | 2010-01-14 | Semiconductor Energy Laboratory Co., Ltd. | Dérivé de carbazole, substance d’élément électroluminescent, élément électroluminescent, et dispositif électroluminescent |
| US20110053866A1 (en) * | 2008-08-12 | 2011-03-03 | Biovail Laboratories International (Barbados) S.R.L. | Pharmaceutical compositions |
| GB2462611A (en) * | 2008-08-12 | 2010-02-17 | Cambridge Lab | Pharmaceutical composition comprising tetrabenazine |
| GB2463451A (en) * | 2008-09-08 | 2010-03-17 | Cambridge Lab | 3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia |
| GB2463452A (en) * | 2008-09-08 | 2010-03-17 | Cambridge Lab | Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof |
| GB2463283A (en) * | 2008-09-08 | 2010-03-10 | Cambridge Lab | 3,11b-cis-dihydrotetrabenazine for use in treating asthma |
| ATE517088T1 (de) * | 2008-09-19 | 2011-08-15 | Semiconductor Energy Lab | Carbazolderivat und herstellungsverfahren dafür |
| US8349898B2 (en) | 2008-11-18 | 2013-01-08 | Wisconsin Alumni Research Foundation | Sigma-1 receptor ligands and methods of use |
| GR1006794B (el) * | 2009-02-26 | 2010-06-04 | Αλεξανδρος Βαμβακιδης | Προσδετες των σιγμα υποδοχεων, αντι-αποπτωτικες και προ-αποπτωτικες ιδιοτητες επι των κυτταρικων μηχανισμων, και με πρωτοτυπη κυτταρο-προστατευτικη αλλα και αντικαρκινικη δραση |
| JP6492432B2 (ja) * | 2013-07-09 | 2019-04-03 | 東ソー株式会社 | アダマンチル基を有する環状アジン化合物、その製造方法、及びそれを構成成分とする有機電界発光素子 |
| KR20170101128A (ko) | 2016-02-26 | 2017-09-05 | 가부시키가이샤 한도오따이 에네루기 켄큐쇼 | 유기 화합물, 발광 소자, 발광 장치, 전자 기기, 및 조명 장치 |
| EP3490556A4 (fr) | 2016-07-27 | 2020-04-15 | Case Western Reserve University | Composés et procédés de stimulation de la myélinisation |
| WO2019126759A1 (fr) * | 2017-12-22 | 2019-06-27 | Convelo Therapeutics, Inc. | Composés et méthodes pour favoriser la myélinisation |
| WO2019126702A1 (fr) | 2017-12-22 | 2019-06-27 | Case Western Reserve University | Composés pour favoriser la myélinisation |
| CA3229664A1 (fr) * | 2021-08-23 | 2023-03-02 | William A. DONALDSON | Synthese et evaluation de nouveaux carbocycles (4-hydroxyphenyl) substitues comme agonistes puissants et selectifs du recepteur beta des ostrogenes |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4104383A (en) * | 1973-11-02 | 1978-08-01 | C M Industries | Derivatives of phenylpropenylamine |
| FR2641276B1 (fr) | 1988-12-30 | 1991-07-12 | Sanofi Sa | Derives du benzene, leur preparation et les compositions pharmaceutiques en contenant |
| WO1991009594A1 (fr) * | 1989-12-28 | 1991-07-11 | Virginia Commonwealth University | Ligands de recepteur sigma et leur emploi |
| ZA909902B (en) * | 1989-12-21 | 1991-10-30 | Himont Inc | Graft copolymers of polyolefins and a method of producing same |
| FR2663328B1 (fr) | 1990-06-14 | 1994-08-05 | Sanofi Sa | Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant. |
| PT100639A (pt) * | 1991-06-27 | 1993-09-30 | Univ Virginia Commonwealth | Metodo para o tratamento terapeutico com compostos que sao ligandos ao receptor sigma e compostos ai utilizados, nomeadamente derivados fenilalquil-amina, aminotetralina,piperazina e piperidina |
| US5449639A (en) | 1994-10-24 | 1995-09-12 | Taiwan Semiconductor Manufacturing Company Ltd. | Disposable metal anti-reflection coating process used together with metal dry/wet etch |
| FR2751645B1 (fr) | 1996-07-29 | 1998-12-24 | Sanofi Sa | Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales |
-
1999
- 1999-06-11 FR FR9907396A patent/FR2794742B1/fr not_active Expired - Fee Related
-
2000
- 2000-06-07 AR ARP000102814A patent/AR033793A1/es active IP Right Grant
- 2000-06-08 AT AT00940462T patent/ATE252542T1/de active
- 2000-06-08 US US10/009,140 patent/US6482986B1/en not_active Expired - Lifetime
- 2000-06-08 SK SK1806-2001A patent/SK286390B6/sk not_active IP Right Cessation
- 2000-06-08 BR BR0011738-2A patent/BR0011738A/pt not_active Application Discontinuation
- 2000-06-08 WO PCT/FR2000/001575 patent/WO2000076953A1/fr active IP Right Grant
- 2000-06-08 JP JP2001503813A patent/JP4711579B2/ja not_active Expired - Fee Related
- 2000-06-08 KR KR1020017015864A patent/KR100668581B1/ko not_active IP Right Cessation
- 2000-06-08 CZ CZ20014443A patent/CZ299659B6/cs not_active IP Right Cessation
- 2000-06-08 DE DE60006113T patent/DE60006113T2/de not_active Expired - Lifetime
- 2000-06-08 HU HU0201953A patent/HU228683B1/hu not_active IP Right Cessation
- 2000-06-08 MX MXPA01012783A patent/MXPA01012783A/es unknown
- 2000-06-08 RU RU2001131414/04A patent/RU2248964C2/ru not_active IP Right Cessation
- 2000-06-08 SI SI200030285T patent/SI1192122T1/xx unknown
- 2000-06-08 IL IL14654500A patent/IL146545A0/xx not_active IP Right Cessation
- 2000-06-08 EP EP00940462A patent/EP1192122B1/fr not_active Expired - Lifetime
- 2000-06-08 ES ES00940462T patent/ES2208345T3/es not_active Expired - Lifetime
- 2000-06-08 CN CNB008088217A patent/CN1210250C/zh not_active Expired - Fee Related
- 2000-06-08 AU AU55396/00A patent/AU768420B2/en not_active Ceased
- 2000-06-08 PT PT00940462T patent/PT1192122E/pt unknown
- 2000-06-08 DK DK00940462T patent/DK1192122T3/da active
- 2000-06-08 CO CO00042775A patent/CO5180554A1/es not_active Application Discontinuation
- 2000-06-08 CA CA2374631A patent/CA2374631C/fr not_active Expired - Fee Related
- 2000-06-08 NZ NZ515529A patent/NZ515529A/xx not_active IP Right Cessation
- 2000-06-08 PL PL352742A patent/PL196491B1/pl not_active IP Right Cessation
- 2000-06-08 RS YUP-871/01A patent/RS49998B/sr unknown
- 2000-06-09 UY UY26199A patent/UY26199A1/es not_active IP Right Cessation
- 2000-06-27 TW TW089111270A patent/TWI279398B/zh not_active IP Right Cessation
- 2000-08-06 UA UA2001117955A patent/UA71959C2/uk unknown
-
2001
- 2001-11-16 ZA ZA200109486A patent/ZA200109486B/en unknown
- 2001-12-10 NO NO20016038A patent/NO327778B1/no not_active IP Right Cessation
-
2002
- 2002-06-24 HK HK02104680.5A patent/HK1042891B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2374631A1 (fr) | Derives du benzene, procede de preparation et compositions pharmaceutiques les contenant | |
| RU2001131414A (ru) | Производные бензола, способ их получения и содержащие их фармацевтические композиции | |
| EP0731794B1 (fr) | Composes du 1,4,5-triphenyle pyrazolyle destines au traitement des inflammations et des troubles lies aux inflammations | |
| EP0508307B1 (fr) | Composé aminé secondaire optiquement actif, procédé pour la préparation d'un tel composé et procédé pour la préparation d'un acide carboxylique optiquement actif par utilisation dudit composé | |
| EP0166615B1 (fr) | Dérivés benzènesulfonamidés | |
| KR101698283B1 (ko) | 티에노피리미딘 화합물의 제조 방법 | |
| JP3998270B2 (ja) | シクロペンタジエニル化合物の製造方法 | |
| EP1586589A4 (fr) | Catalyseurs de polymerisation d'olefines et procedes de production d'un polymere olefinique | |
| CA2369393A1 (fr) | Procede pour la preparation du (1r,2s,4r)-(-)-2-¬(2'-{n,n-dimethylamino}-ethoxy)|-2-¬phenyl|-1,7,7-tri-¬meth yl|-bicyclo¬2.2.1|heptane hautement pur et des sels d'addition acide pharmaceutiquement acceptables de ce produit ainsi que des medicaments renfermant au moins 1 de ces composes et leur utilisation | |
| EP1196403B1 (fr) | N-aralkyl amines cycliques antipsychotiques | |
| JP2000007692A (ja) | 新規メタロセン化合物及びその製造方法 | |
| US5110830A (en) | Benzenesulfonamides treatment of tumors susceptible to | |
| JP2003503487A5 (fr) | ||
| JP4116684B2 (ja) | メチレン橋架けビスシクロペンタジエニル化合物の製造法 | |
| KR101450359B1 (ko) | 디알킬 옥사이드 메탈로센 또는 디아릴 옥사이드 메탈로센의 제조방법 | |
| EP1257516B1 (fr) | Procede de fabrication de bisindenylalcanes | |
| TWI797784B (zh) | 環戊二烯的選擇性烷基化 | |
| TH24567B (th) | อนุพันธ์เบนซีนชนิดใหม่ กรรมวิธีสำหรับการเตรียมสารเหล่านี้และสารผสมทางเภสัชกรรมซึ่งมีสารดังกล่าว | |
| TH46054A (th) | อนุพันธ์เบนซีนชนิดใหม่ กรรมวิธีสำหรับการเตรียมสารเหล่านี้และสารผสมทางเภสัชกรรมซึ่งมีสารดังกล่าว | |
| Bajpai et al. | Novel skeletal rearrangement of substituted-2-nitro-1, 3-dienes to 1-nitro-1, 3-dienes: An easy access to a new class of cyclohexene derivatives | |
| US3519640A (en) | 4-substituted-1,2-diphenyl-3,5-dioxo-pyrazolidines | |
| JP3590820B2 (ja) | 複核メタロセン錯体 | |
| JP3055246B2 (ja) | １，１，３，４，４，６−ヘキサメチルテトラリンの製造法 | |
| CA1040647A (fr) | Derives de amino-3 prop-1-enes | |
| JP2008247745A (ja) | メタクリル酸エステルの製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20160608 |